# Bioequivalence Study of Spironolactone Tablets in Healthy Subjects

> **NCT06579053** · PHASE1 · COMPLETED · sponsor: **SPH Sine Pharmaceutical Laboratories Co., Ltd.** · enrollment: 64 (actual)

## Conditions studied

- Bioequivalence Study

## Interventions

- **DRUG:** Spironolactone Tablets (Test)
- **DRUG:** Spironolactone Tablets (Reference)

## Key facts

- **NCT ID:** NCT06579053
- **Lead sponsor:** SPH Sine Pharmaceutical Laboratories Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-22
- **Primary completion:** 2023-05-05
- **Final completion:** 2023-08-23
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2024-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06579053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06579053, "Bioequivalence Study of Spironolactone Tablets in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06579053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*